Preoperative serum levels of c-erbB-2 do not seem to be useful in management of patients with rectal cancer

International Journal of Colorectal Disease

Volumn 22, Issue 7, 2007, Pages 827-831

  Kovačevi, Dujo ^a   Sonicki, Zdenko ^b   Kusi, Zvonko ^a   Bolanča, Ante ^a   Grubiši, Goran ^a   Lukač, Maja ^a   Lukač, Josip ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b School of Health Studies   (Croatia)

Author keywords

Follow up; Rectal cancer; Solublec erbB 2 HER 2 neu; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECTUM CANCER; RECTUM CARCINOMA; SENSITIVITY AND SPECIFICITY;

EID: 34249874613     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0200-z     Document Type: Article

References (17)

1. Zabrecky JR, Lam T, McKenzie SJ, Carney W (1991) The extracellular domain of p185/neu is released from the surface of human breast carcinoma cell, SK-BR-3. J Biol Chem 266:1716-1720
2. Leitzel K, Teramoto Y, Sampson E, Mauceri J, Langton B, Demers L, Podczaski E, Harvey H, Shambaugh S, Volas G, Weaver S, Lipton A (1992) Elevated soluble c-erbB-2 antigen levels in the sera and effusions of a proportion of breast cancer patients. J Clin Oncol 10:1436-1443
3. Narita T, Funahashi H, Satoh Y, Takagi H (1992) C-erbB-2 protein in the sera of breast cancer patients. Breast Cancer Res Treat 24:97-102
4. Luo JC, Yu MW, Chen CJ, Santella RW, Carney WP, Brandt-Rauf PW (1993) Serum c-erbB-2 oncopeptide in hepatocellular carcinogenesis. Med Sci Res 21:305-307
5. Yonemura Y, Nakai Y, Takamura H, Kaji M, Ninomiya i, Tsugawa K, Sugiyama K, Fujimura T, Miyazaki I, Endou Y, Tanaka M, Sasaki T, Hashimoto T (1993) Serum c-erbB-2 protein for the diagnosis of gastric cancer. Int J Oncol 3:325-329
6. Marx D, Fattahi-Meibodi A, Kudelka R, Uebel T, Kuhn W, Meden H (1998) Detection of p100 (c-erbB-2, HER2/neu) serum levels by a new ELISA in patients with ovarian carcinoma. Anticancer Res 18:2891-2894
7. Kandl H, Seymour L, Bezwoda WR (1994) Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer. BR J Cancer 70:739-742
8. Leitzel K, Teramoto Y, Konrad K, Chinchilli VM, Volas G, Grossberg H, Harvey H, Demers L, Lipton A (1995) Elevated serum c-c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. J Clin Oncol 13:1129-1135
9. Classen S, Kopp R, Possinger K, Weidenhagen R, Eiermann W, Wilmanns W (2002) Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy. Tumor Biol 23:70-75
10. Vogel W, Kath R, Kosmehl H, Olschowsky E, Hoffken K (1996) The neu oncogene product in serum and tissue of patients with metastatic gastrointestinal carcinomas. J Cancer Res Clin Oncol 122:118-121
11. Molina R, Jo J, Filella X, Bruix J, Castells A, Hague M, Ballesta AM (1997) Serum levels of c-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases. Tumor Biol 18:188-196
12. Lukač J, Kovačevi D, Krušlin B, Spaventi R, Ferenčić, Belicza M, DeSyo D, Kusi Z (1998) Relationship between natural killer (NK) cell activity and erbB-2 expression in colorectal cancer patients. Period Biol 100:537-539
13. Chamberlain NL, Ward RL, Hawkins NJ (1999) Clinicopathological significance of erbB-2 expression in colorectal carcinoma. Oncol Rep 6:527-531
14. Tsigris C, Karayiannakis AJ, Zbar A, Syrigos KN, Baibas N, Diamantis T, Alexiou D (2002) Clinical significance of serum and urinary c-erbB-2 levels in colorectal cancer. Cancer Lett 184:215-222
15. Polychronidis AC, Tsaroucha AK, Anagnostoulis SK, Efstathiou EE, Georgiadis PG, Simopoulos CE (2003) Serum levels of c-erbB-2 correlate with advanced stage and liver metastasis in colorectal cancer. Folia Med (Plovdiv) 45:12-16
16. Colon and rectum (1997) In: American Joint Committee on Cancer: AJCC cancer staging manual, 5th edn. Lippincott-Raven, Philadelphia, pp 83-90
17. World Medical Association. Declaration of Helsinki. Available at: http://www.wma.net/e/policy/b3.htm